Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5604464 | International Journal of Cardiology | 2017 | 20 Pages |
Abstract
Gastrointestinal ADEs after starting subcutaneous treprostinil were associated with an increased risk for mortality. Increased mortality was not observed with other early ADEs or with gastrointestinal symptoms in participants who were not receiving treprostinil at the time. This hypothesis-generating association suggests ADEs may identify different phenotypes in PAH.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Peter J. Leary, Suhyun Kang, Todd M. Kolb, Bradley A. Maron, David D. Ralph, Youlan Rao, Ryan J. Tedford, Roham T. Zamanian,